Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Discovery of a multipotent cell type from the term human placenta

Discovery of a multipotent cell type from the term human placenta

FromPaperPlayer biorxiv cell biology


Discovery of a multipotent cell type from the term human placenta

FromPaperPlayer biorxiv cell biology

ratings:
Length:
20 minutes
Released:
Aug 4, 2023
Format:
Podcast episode

Description

Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.08.02.551028v1?rss=1

Authors: Vadakke-Madathil, S., Wang, B., Oniskey, M., Dekio, F., Brody, R., Gelber, S., Sperling, R., Chaudhry, H. W.

Abstract:
The human placenta is a reservoir of a multitude of cell types with immense regenerative potential. Caudal-type homeobox-2 (CDX2) is a conserved factor that regulates trophectoderm formation and placentation during early embryonic development and hence can play a vital role in understanding developmentally conserved regenerative mechanisms. Cdx2 lineage tracing in our previous study identified multipotent Cdx2 lineage cells in the mouse placenta capable of restoring cardiac function after intravenous delivery in male mice with experimental cardiac injury (myocardial infarction). Here we demonstrate that CDX2-expressing cells are prevalent in the human chorionic placenta and are uniquely committed to cardiovascular differentiation. We examined the term placentas from 106 healthy donors and showed that isolated CDX2 cells can spontaneously differentiate into cardiomyocytes, functional vascular cells, and retain homing ability in vitro. Functional annotation from transcriptomics analysis supports enhanced cardiogenesis, vasculogenesis, immune modulation, and chemotaxis gene signatures in CDX2 cells. CDX2 cells can be clonally propagated in culture with retention of cardiovascular differentiation. Bringing us a step closer to translation, our study identifies an easily accessible and ethically feasible cell source to facilitate therapeutic strategies for cardiovascular disease.

Copy rights belong to original authors. Visit the link for more info

Podcast created by Paper Player, LLC
Released:
Aug 4, 2023
Format:
Podcast episode

Titles in the series (100)

Audio versions of bioRxiv and medRxiv paper abstracts